Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination.
Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination.
复制标题
DOI:
10.1186/s12979-020-00210-z
复制
发表时间:
2020-11-19
期刊:
影响因子:
--
通讯作者:
Blomberg BB
中科院分区:
文献类型:
--
作者:
Frasca D;Blomberg BB
Aging is characterized by a progressive decline in the capacity of the immune system to fight influenza virus infection and to respond to vaccination. Among the several factors involved, in addition to increased frailty and high-risk conditions, the age-associated decrease in cellular and humoral immune responses plays a relevant role. This is in large part due to inflammaging, the chronic low-grade inflammatory status of the elderly, associated with intrinsic inflammation of the immune cells and decreased immune function. Aging is usually associated with reduced influenza virus-specific and influenza vaccine-specific antibody responses but some elderly individuals with higher pre-exposure antibody titers, due to a previous infection or vaccination, have less probability to get infected. Examples of this exception are the elderly individuals infected during the 2009 pandemic season who made antibodies with broader epitope recognition and higher avidity than those made by younger individuals. Several studies have allowed the identification of B cell intrinsic defects accounting for sub-optimal antibody responses of elderly individuals. These defects include 1) reduced class switch recombination, responsible for the generation of a secondary response of class switched antibodies, 2) reduced de novo somatic hypermutation of the antibody variable region, 3) reduced binding and neutralization capacity, as well as binding specificity, of the secreted antibodies, 4) increased epigenetic modifications that are associated with lower antibody responses, 5) increased frequencies of inflammatory B cell subsets, and 6) shorter telomeres. Although influenza vaccination represents the most effective way to prevent influenza infection, vaccines with greater immunogenicity are needed to improve the response of elderly individuals. Recent advances in technology have made possible a broad approach to better understand the age-associated changes in immune cells, needed to design tailored vaccines and effective therapeutic strategies that will be able to improve the immune response of vulnerable individuals.
登录
查看更多内容
DOI:
10.4049/jimmunol.1900922
发表时间:
2020-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Avey S;Mohanty S;Chawla DG;Meng H;Bandaranayake T;Ueda I;Zapata HJ;Park K;Blevins TP;Tsang S;Belshe RB;Kaech SM;Shaw AC;Kleinstein SH
通讯作者:
Kleinstein SH
DOI:
10.1084/jem.20171127
发表时间:
2018-05-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fang D;Cui K;Hu G;Gurram RK;Zhong C;Oler AJ;Yagi R;Zhao M;Sharma S;Liu P;Sun B;Zhao K;Zhu J
通讯作者:
Zhu J
影响因子:
12.7
作者:
Ding, Qiang;Lu, Panpan;Liu, Mei
通讯作者:
Liu, Mei
影响因子:
15.3
作者:
Didierlaurent, Arnaud;Goulding, John;Patel, Seema;Snelgrove, Robert;Low, Lionel;Bebien, Magali;Lawrence, Toby;van Rijt, Leonie S.;Lambrecht, Bart N.;Sirard, Jean-Claude;Hussell, Tracy
通讯作者:
Hussell, Tracy
影响因子:
5.3
作者:
Beli, Eleni;Clinthorne, Jonathan F.;Duriancik, David M.;Hwang, Ilwoong;Kim, Sungjin;Gardner, Elizabeth M.
通讯作者:
Gardner, Elizabeth M.